Facebook Linkedin Pinterest Reddit Twitter
UroCure
UroCure Arc Sling Systems Portfolio
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
1 min.Read

UroCure Expands SUI Sling Portfolio with the Nationwide Launch of the ArcSP and ArcTO Slings

ArcSP™ Suprapubic Sling System and the ArcTO™ Transobturator Sling System

UroCure and LiNA Medical USA are pleased to announce the nationwide launch of UroCure’s two latest innovations of surgical solutions for female stress urinary incontinence: the ArcSP™ Suprapubic Sling System and the ArcTO™ Transobturator Sling System.

UroCure ArcTV® Transvaginal Sling

These two additions complement the current UroCure ArcTV® Transvaginal Sling on the market. ArcSP will now provide a top-down, retropubic approach and ArcTO will accommodate surgeons that prefer an outside-in, transobturator approach. All three systems are based on AMS’ best-in-class slings, while incorporating UroCure’s laser cut sling with its patented stabilizing suture. The absorbable stabilizing suture is a key innovation of UroCure’s sling designed to maintain its open pore structure and to protect the sling from deformation during placement, tensioning, and sheath removal.

John Nealon, CEO of UroCure

“At UroCure, our mission has always been to empower patients and physicians with innovative solutions. The nationwide launch of ArcTO and ArcSP represents a significant milestone in our commitment to expand our product offerings and offer cutting-edge solutions for the treatment of stress urinary incontinence.”

Collaboration with LiNA Medical USA

UroCure’s collaboration with LiNA Medical USA, further amplifies the reach and impact of these additional slings. Lars Melbye, President of LiNA Medical USA shared his enthusiasm for the partnership, saying, “We are thrilled to continue our partnership with UroCure by introducing the ArcTO and ArcSP to the U.S. market nationwide. LiNA Medical USA has seen the immense value the ArcTV sling system adds for surgeons and their patients. Now offering three sling solutions will be an impactful offering nationwide.”

More Information

For more information about UroCure’s Arc sling systems portfolio, please visit UroCure’s website https://urocure.com or contact LiNA Medical to connect with your local sales representative (info@linamed.com, 855-546-2633).

SourceUroCure

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330

Exit mobile version